Differential in vitro interactions of the Janus kinase inhibitor ruxolitinib with human SLC drug transporters-Reference-Cited by-同舟云学术

Differential in vitro interactions of the Janus kinase inhibitor ruxolitinib with human SLC drug transporters

Author:

Bruyère Arnaud¹,Le Vée Marc¹,Jouan Elodie¹,Molez Stephanie¹,Nies Anne T.²³,Fardel Olivier⁴

Affiliation:

1. Univ Rennes, Inserm, EHESP, Irset (Institut de recherche en santé, environnement et travail) – UMR_S 1085, Rennes, France

2. Dr. Margarete Fischer-Bosch Institute of Clinical Pharmacology, Stuttgart and University of Tübingen, Stuttgart, Germany

3. iFIT Cluster of Excellence (EXC2180) "Image Guided and Functionally Instructed Tumor Therapies", University of Tübingen, Tübingen, Germany

4. Univ Rennes, CHU Rennes, Inserm, EHESP, Irset (Institut de recherche en santé, environnement et travail) – UMR_S 1085, Rennes, France

Publisher

Informa UK Limited

Subject

Health, Toxicology and Mutagenesis,Pharmacology,Toxicology,Biochemistry,General Medicine

Link

Reference56 articles.

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献